BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program

Go back to BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
(AMEX: BMKDF) Delayed: 0.39 --0 (-0%)
Previous Close $0.39    52 Week High $0.14 
Open $0.39    52 Week Low $0.04 
Day High $0.39    P/E N/A 
Day Low $0.39    EPS $0.00 
Volume 114,626